0.8936
price down icon0.53%   -0.0048
after-market アフターアワーズ: .90 0.0064 +0.72%
loading

Tempest Therapeutics Inc (TPST) 最新ニュース

pulisher
Nov 18, 2024

William Blair Has Negative Estimate for TPST FY2024 Earnings - Defense World

Nov 18, 2024
pulisher
Nov 16, 2024

Research Analysts Offer Predictions for TPST FY2024 Earnings - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

500: Something went wrong - Investing.com Canada

Nov 15, 2024
pulisher
Nov 15, 2024

TPST Stock Plummets to 52-Week Low at $0.85 Amid Market Struggles - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

HC Wainwright Reiterates “Buy” Rating for Tempest Therapeutics (NASDAQ:TPST) - Defense World

Nov 15, 2024
pulisher
Nov 13, 2024

Tempest Therapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Tempest Therapeutics price target lowered to $5 from $8 at Piper Sandler - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

TPSTTempest Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 13, 2024
pulisher
Nov 12, 2024

Tempest Therapeutics advances liver cancer drug to Phase 3 trial By Investing.com - Investing.com Canada

Nov 12, 2024
pulisher
Nov 12, 2024

Tempest Therapeutics reports Q3 EPS (41c), consensus (36c) - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Tempest Therapeutics advances liver cancer drug to Phase 3 trial - Investing.com India

Nov 12, 2024
pulisher
Nov 12, 2024

Tempest Receives FDA Study May Proceed for Pivotal Phase 3 - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Tempest Gets FDA Green Light for Pivotal Phase 3 Liver Cancer Drug Trial | TPST Stock | TPST Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Tempest Therapeutics (TPST) Stock Jumps 83% On FDA Phase 3 Trial News - Barchart

Nov 12, 2024
pulisher
Oct 30, 2024

TPST stock touches 52-week low at $0.91 amid market challenges - Investing.com UK

Oct 30, 2024
pulisher
Oct 16, 2024

Take off with Tempest Therapeutics Inc (TPST): Get ready for trading - SETE News

Oct 16, 2024
pulisher
Oct 15, 2024

Market Momentum: Tempest Therapeutics Inc (TPST) Registers a 4.39 Increase, Closing at 1.07 - The Dwinnex

Oct 15, 2024
pulisher
Oct 14, 2024

TPST stock touches 52-week low at $0.92 amid market challenges By Investing.com - Investing.com South Africa

Oct 14, 2024
pulisher
Oct 14, 2024

Tempest Therapeutics Inc (TPST) Stock: A Year of Market Movement, Down and Up - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Tempest Therapeutics maintains stock target, sector outperform rating - Investing.com

Oct 14, 2024
pulisher
Oct 14, 2024

Tempest Therapeutics maintains stock target, sector outperform rating By Investing.com - Investing.com South Africa

Oct 14, 2024
pulisher
Oct 14, 2024

TPST stock touches 52-week low at $0.92 amid market challenges - Investing.com

Oct 14, 2024
pulisher
Oct 14, 2024

Was Tempest Therapeutics Inc (TPST)’s session last reading good? - US Post News

Oct 14, 2024
pulisher
Oct 11, 2024

Tempest Therapeutics Inc [TPST] Stock trading around $1.10 per share: What’s Next? - The DBT News

Oct 11, 2024
pulisher
Oct 11, 2024

Tempest Therapeutics Inc [NASDAQ: TPST] Sees Decrease in Stock Value - Knox Daily

Oct 11, 2024
pulisher
Oct 11, 2024

Tempest Therapeutics shares retain Buy rating post Roche deal - Investing.com

Oct 11, 2024
pulisher
Oct 11, 2024

Market Momentum: Tempest Therapeutics Inc (TPST) Registers a -18.52 Decrease, Closing at 1.10 - The Dwinnex

Oct 11, 2024
pulisher
Oct 11, 2024

Tempest Therapeutics shares retain Buy rating post Roche deal By Investing.com - Investing.com UK

Oct 11, 2024
pulisher
Oct 10, 2024

Tempest Therapeutics Inc (TPST) Stock: A Year of Market Fluctuations - The InvestChronicle

Oct 10, 2024
pulisher
Oct 10, 2024

TPST’s price-to-free cash flow ratio: What it means for investors - US Post News

Oct 10, 2024
pulisher
Oct 10, 2024

Tempest Therapeutics jumps on agreement with Roche to advance liver cancer drug study - XM

Oct 10, 2024
pulisher
Oct 10, 2024

Why Is Cancer Focused Tempest Therapeutics Stock Trading Higher On Thursday? - Yahoo Finance

Oct 10, 2024
pulisher
Oct 10, 2024

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Oct 10, 2024
pulisher
Oct 10, 2024

Tempest Therapeutics to Advance Liver Cancer Drug to Phase 3 Trial with Roche; Shares Jump Pre-Bell - Marketscreener.com

Oct 10, 2024
pulisher
Oct 10, 2024

Tempest stock gains on Roche collaboration (NASDAQ:TPST) - Seeking Alpha

Oct 10, 2024
pulisher
Oct 10, 2024

Tempest Therapeutics partners with Roche on cancer trial - Investing.com

Oct 10, 2024
pulisher
Oct 10, 2024

Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial - ForexTV.com

Oct 10, 2024
pulisher
Oct 10, 2024

Tempest Therapeutics, Inc Enters into Master Clinical Supply Agreement with F. Hoffmann-La Roche Ltd. to Which Roche Will Supply Roche?S Atezolizumab - Marketscreener.com

Oct 10, 2024
pulisher
Oct 10, 2024

Tempest Extends Limited Duration Stockholder Rights Plan - GlobeNewswire

Oct 10, 2024
pulisher
Oct 10, 2024

Tempest Announces Agreement with Roche to Support - GlobeNewswire

Oct 10, 2024
pulisher
Oct 04, 2024

Healthy Upside Potential: Tempest Therapeutics Inc (TPST) - SETE News

Oct 04, 2024
pulisher
Oct 03, 2024

TPST Shares Experience Surge in Value - Knox Daily

Oct 03, 2024
pulisher
Oct 03, 2024

How to interpret Tempest Therapeutics Inc (TPST)’s stock chart patterns - US Post News

Oct 03, 2024
pulisher
Sep 24, 2024

Scotiabank initates Tempest Therapeutics Inc (TPST) rating to a Sector outperform - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Quarterly Metrics: Quick and Current Ratios for Tempest Therapeutics Inc (TPST) - The Dwinnex

Sep 24, 2024
pulisher
Sep 23, 2024

Sigourney Weaver to star in Jamie Lloyd's 'The Tempest' this fall - LondonTheatre.co.uk

Sep 23, 2024
pulisher
Sep 23, 2024

A Closer Look at Tempus AI Inc. (TEM) Stock Gains - The InvestChronicle

Sep 23, 2024
pulisher
Sep 23, 2024

The Tempest cast announced to join Sigourney Weaver at the Theatre Royal Drury Lane in London - WestEndTheatre.com

Sep 23, 2024
pulisher
Sep 23, 2024

See Who's Joining Sigourney Weaver in West End The Tempest - Playbill

Sep 23, 2024
pulisher
Sep 23, 2024

Davidson Kempner Capital Management LP Acquires New Shares in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Full Cast Announced for The Tempest at Theatre Royal Drury Lane - London Theatre 1

Sep 23, 2024
pulisher
Sep 23, 2024

Gavin & Stacey star joins Sigourney Weaver in The Tempest - RadioTimes

Sep 23, 2024
pulisher
Sep 23, 2024

The Tempest with Sigourney Weaver at Theatre Royal Drury Lane announces complete casting - WhatsOnStage.com

Sep 23, 2024
pulisher
Sep 23, 2024

Full cast announced for Jamie Lloyd Company’s THE TEMPEST at Theatre Royal Drury Lane - West End Best Friend

Sep 23, 2024
pulisher
Sep 22, 2024

Brokerages Set Tempus AI, Inc. (NASDAQ:TEM) Price Target at $45.56 - MarketBeat

Sep 22, 2024
pulisher
Sep 20, 2024

Tempus AI (NASDAQ:TEM) Shares Gap Up to $50.09 - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sep 20, 2024
pulisher
Sep 20, 2024

Tempus AI (NASDAQ:TEM) Shares Down 5.3% - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Deeper Dive: Understanding Tempus AI Inc. (TEM) Through its Various Ratios - The Dwinnex

Sep 19, 2024
pulisher
Sep 19, 2024

Just the Facts: Tempest Minerals begins fieldwork at Five Wheel Project - Proactive Investors UK

Sep 19, 2024
pulisher
Sep 18, 2024

Tempus AI Inc. [TEM] Investment Guide: What You Need to Know - Knox Daily

Sep 18, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
大文字化:     |  ボリューム (24 時間):